HSCS logo

Heart Test Laboratories (HSCS) Company Overview

Profile

Full Name:

HeartSciences Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

June 16, 2022

Indexes:

Not included

Website:

http://heartsciences.com

Description:

HSCS (Heart Test Laboratories) specializes in advanced heart health testing. They provide innovative diagnostic services to help identify heart conditions early. Their goal is to improve patient outcomes through accurate testing and personalized care, making heart health accessible and understandable for everyone.

Key Details

Price

$3.07

Market Cap

$3.01 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$18.60 K(+257.69% YoY)

Annual EPS

-$19.00(+76.25% YoY)

PE Ratio

-

Annual ROE

-175.02%

Annual Debt To Equity

0.07

Beta

1.54

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 17, 2024

Analyst ratings

Recent major analysts updates

Dec 18, 24 Maxim Group
Buy
Sep 23, 24 Ascendiant Capital
Buy
Jan 30, 23 Ascendiant Capital
Buy
Dec 19, 22 Maxim Group
Buy
Nov 9, 22 Maxim Group
Buy
Aug 8, 22 Benchmark
Speculative Buy

Screeners with HSCS included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.07
HSCS price is $3.07

Price All-time High

$340.00
HSCS price is currently -99.10% below its historical high of $340.00

Price Analysts Target

$13.50
HSCS price is currently -77.26% lower than the consensus analysts' forecast

Price Most Recent Change

-4.06%
HSCS price was down -4.06% on Mar 5, 2025

Price YTD Change

-15.43%
HSCS price is down -15.43% since January 1st

Price 3-Year Change

-
HSCS price 3-year change is unknown

Market cap

Market Cap

$3.01 M
HSCS market capitalization is $3.01 million

Market Cap 3-Year Change

-
HSCS market capitalization 3-year change is unknown

Market Cap All-time High

$28.39 M
HSCS market capitalization is currently -89.40% below its historical high of $28.39 million

Market Cap Sector Rank

8.97%
HSCS market capitalization is higher than 8.97% of companies in Healthcare sector

Technical

Beta

1.54
HSCS beta is 1.54

200-day SMA

$3.88
HSCS price is currently -20.89% below its 200-day simple moving average

14-day RSI

33.94
HSCS 14-day relative strength index is 33.94

30-day Relative Volume

1.95
HSCS 30-day relative volume is 1.95

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$18.60 K
HSCS annual revenue is $18.60 thousand

Annual Revenue Analysts Estimate

$50.00 K
HSCS annual revenue is currently -62.80% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+257.69%
HSCS annual revenue is up +257.69% year-on-year

Annual Revenue Sector Rank

5.6%
HSCS annual revenue is higher than 5.6% of companies in Healthcare sector

Profit

Annual Gross Profit

$12.50 K
HSCS annual gross profit is $12.50 thousand

Annual Gross Margin

67.31%
HSCS annual gross profit margin is 67.31%

Annual Operating Profit

-$6.31 M
HSCS annual operating income is -$6.31 million

Annual Operating Margin

-33.90 K%
HSCS annual operating profit margin is -33.90 thousand%

Annual Net Income

-$6.61 M
HSCS annual net profit is -$6.61 million

Annual Net Margin

-35.51 K%
HSCS annual net profit margin is -35.51 thousand%

EPS

Annual EPS

-$19.00
HSCS annual earnings per share is -$19.00

Annual EPS Analysts Estimate

-$9.32
HSCS annual earnings per share is currently +103.86% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+76.25%
HSCS annual earnings per share is up +76.25% year-on-year

Annual EPS Sector Rank

10.79%
HSCS annual earnings per share is higher than 10.79% of companies in Healthcare sector

ROA & ROE

Annual ROA

-103.28%
HSCS annual return on assets is -103.28%

Annual ROE

-175.02%
HSCS annual return on equity is -175.02%

EBIT & EBITDA

Annual EBIT

-$6.25 M
HSCS annual earnings before interest & taxes is -$6.25 million

Annual EBITDA

-$6.16 M
HSCS annual EBITDA is -$6.16 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
HSCS price to earnings ratio value is unknown

PE Ratio Sector Rank

-
HSCS price to earnings ratio is unknown

PB Ratio

PB Ratio

0.75
HSCS price to book ratio is 0.75

PB Ratio Sector Rank

36.22%
HSCS price to book ratio is higher than 36.22% of companies in Healthcare sector

PS Ratio

PS Ratio

-
HSCS price to sales ratio value is unknown

PS Ratio Sector Rank

-
HSCS price to sales ratio is unknown

Enterprise value

Enterprise Value

$1.86 M
HSCS enterprise value is $1.86 million

Enterprise Value Sector Rank

14.48%
HSCS enterprise value is higher than 14.48% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.26
HSCS EV/EBITDA is -0.26

EV/EBITDA Sector Rank

59.59%
HSCS EV/EBITDA is higher than 59.59% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.20
HSCS annual current ratio is 4.20

Annual Quick Ratio

3.84
HSCS annual quick ratio is 3.84

Leverage

Annual Debt To Equity

0.07
HSCS annual debt to equity ratio is 0.07

Annual Interest Coverage Ratio

-17.65
HSCS annual interest coverage ratio is -17.65

Risk & Stability

Piotroski F-Score

-
HSCS piotroski f-score value is unknown

Altman Z-Score

-10.56
HSCS altman z-score is -10.56

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$9.50 M
HSCS annual total assets is $9.50 million

Annual Non Current Assets

$2.15 M
HSCS annual long term assets is $2.15 million

Annual Current Assets

$7.35 M
HSCS annual total current assets is $7.35 million

Annual Cash & Cash Equivalents

$5.81 M
HSCS annual cash & cash equivalents is $5.81 million

Equity

Annual Book Value

$7.32 M
HSCS annual book value is $7.32 million

Annual Working Capital

$5.60 M
HSCS annual working capital is $5.60 million

Liabilities

Annual Total Liabilities

$2.19 M
HSCS annual total liabilities is $2.19 million

Annual Total Long Term Liabilities

$434.00 K
HSCS annual total long term liabilities is $434.00 thousand

Annual Current Liabilities

$1.75 M
HSCS annual total current liabilities is $1.75 million

Annual Accounts Payable

$448.20 K
HSCS annual accounts payable is $448.20 thousand

Debt

Annual Total Debt

$1.04 M
HSCS annual total debt is $1.04 million

Annual Total Debt 1-Year Change

-33.82%
HSCS annual total debt is down -33.82% year-on-year

Annual Long Term Debt

$434.00 K
HSCS annual long term debt is $434.00 thousand

Annual Short Term Debt

$602.30 K
HSCS annual short term debt is $602.30 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$6.32 M
HSCS annual total expenses is $6.32 million

Annual Operating Expenses

$6.32 M
HSCS annual total operating expenses is $6.32 million

Annual Cost Of Goods Sold

$6100.00
HSCS annual cost of goods sold is $6100.00

Annual SGA

$3.44 M
HSCS annual SGA is $3.44 million

Annual D&A

$95.10 K
HSCS annual depreciation & amortization is $95.10 thousand

Annual Interest Expense

$354.10 K
HSCS annual interest expense is $354.10 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$6.07 M
HSCS annual cash flow from operations is -$6.07 million

Annual CFO 1-Year Change

-5.14%
HSCS annual cash flow from operations is down -5.14% year-on-year

Annual CFI

-$125.30 K
HSCS annual cash flow from investing activities is -$125.30 thousand

Annual CFI 1-Year Change

-584.7%
HSCS annual cash flow from investing activities is down -584.7% year-on-year

Annual CFF

$10.34 M
HSCS annual cash flow from financing activities is $10.34 million

Annual CFF 1-Year Change

+58.29%
HSCS annual cash flow from financing activities is up +58.29% year-on-year

Free CashFlow

Annual FCF

-$6.20 M
HSCS annual free cash flow is -$6.20 million

Annual FCF 1-Year Change

-6.97%
HSCS annual free cash flow is down -6.97% year-on-year

CAPEX

Annual CAPEX

$125.30 K
HSCS annual capital expenditures is $125.30 thousand

Annual CAPEX 1-Year Change

+584.7%
HSCS annual capital expenditures is up +584.7% year-on-year

Institutional Ownership

Similar stocks

LIPO logo
Lipella Pharmaceuticals (LIPO)
NIVF logo
NewGenIvf Group Limited (NIVF)
Klotho Neurosciences (KLTO)
NBY logo
NovaBay Pharmaceuticals (NBY)
GNPX logo
Genprex (GNPX)
TIVC logo
Tivic Health Systems (TIVC)
TLIS logo
Talis Biomedical (TLIS)
Scinai Immunotherapeutics (SCNI)
GLMD logo
Galmed Pharmaceuticals (GLMD)

FAQ

  • What is the ticker symbol for Heart Test Laboratories?
  • Does Heart Test Laboratories pay dividends?
  • What sector is Heart Test Laboratories in?
  • What industry is Heart Test Laboratories in?
  • What country is Heart Test Laboratories based in?
  • When did Heart Test Laboratories go public?
  • Is Heart Test Laboratories in the S&P 500?
  • Is Heart Test Laboratories in the NASDAQ 100?
  • Is Heart Test Laboratories in the Dow Jones?
  • When does Heart Test Laboratories report earnings?
  • Should I buy Heart Test Laboratories stock now?

What is the ticker symbol for Heart Test Laboratories?

The ticker symbol for Heart Test Laboratories is NASDAQ:HSCS

Does Heart Test Laboratories pay dividends?

No, Heart Test Laboratories does not pay dividends

What sector is Heart Test Laboratories in?

Heart Test Laboratories is in the Healthcare sector

What industry is Heart Test Laboratories in?

Heart Test Laboratories is in the Medical Devices industry

What country is Heart Test Laboratories based in?

Heart Test Laboratories is headquartered in United States

When did Heart Test Laboratories go public?

Heart Test Laboratories's initial public offering (IPO) was on June 16, 2022

Is Heart Test Laboratories in the S&P 500?

No, Heart Test Laboratories is not included in the S&P 500 index

Is Heart Test Laboratories in the NASDAQ 100?

No, Heart Test Laboratories is not included in the NASDAQ 100 index

Is Heart Test Laboratories in the Dow Jones?

No, Heart Test Laboratories is not included in the Dow Jones index

When does Heart Test Laboratories report earnings?

The date for Heart Test Laboratories's next earnings report has not been announced yet

Should I buy Heart Test Laboratories stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions